Procter & Gamble CO Form 4 insider transactions

Moses Victor Javier Aguilar, a Chief Research, Development & Innovation Officer at Procter & Gamble, reported the acquisition and disposal of company stock and derivative securities.

Alexandra Keith R., CEO Beauty at Procter & Gamble, filed a Form 4 disclosing changes in beneficial ownership of company stock.

Ma. Fatima Francisco, a Procter & Gamble executive, reported exercising stock options and selling shares on May 8, 2024.

Gary A. Coombe, CEO Grooming at Procter & Gamble, exercised stock options and sold shares on May 7, 2024.

Chief Operating Officer of Procter & Gamble, Shailesh Jejurikar, exercised stock options and sold shares on May 6, 2024.

Procter & Gamble's Chief Operating Officer, Shailesh Jejurikar, reported the acquisition and disposal of company stock and derivative securities on April 30, 2024.

Balaji Purushothaman, Chief Human Resources Officer at Procter & Gamble, exercised stock options and sold shares on April 23, 2024, according to a Form 4 filing with the SEC.

Alexandra Keith, CEO Beauty at Procter & Gamble, reported the sale of 855 shares of common stock at $158.50 on April 22, 2024.

Director Patricia A. Woertz reports acquisition of 185 Restricted Stock Units in Procter & Gamble, increasing her holdings to 47,371.6558 shares.

Director Robert Portman reports acquiring 47 shares of Procter & Gamble common stock on March 12, 2024, through the grant of restricted stock units and dividend equivalents.

Director Ashley McEvoy reports acquiring 155 shares of Procter & Gamble common stock on March 12, 2024, through the company's 2019 Stock and Incentive Compensation Plan.

Director Christine M. McCarthy reports the acquisition of 171 Restricted Stock Units of Procter & Gamble common stock on March 12, 2024.

Director Terry J. Lundgren reports acquiring 193 shares of Procter & Gamble common stock through restricted stock units and dividend reinvestment.

Director Joseph Jimenez reports acquiring 263 shares of Procter & Gamble common stock in the form of restricted stock units.

Director Christopher Kempczinski reports acquisition of Procter & Gamble restricted stock units on March 12, 2024.

Director Angela F. Braly reports acquiring 186 shares of Procter & Gamble common stock on March 12, 2024, bringing her total holdings to 57,464.3174 shares.

Director M. Brett Biggs reports acquisition of 155 shares of Procter & Gamble common stock and dividend equivalents in the form of Restricted Stock Units.

Director B. Marc Allen acquired 155 Restricted Stock Units of Procter & Gamble on March 12, 2024, at no cost.

Alexandra Keith, CEO Beauty at Procter & Gamble, reported the sale of 776 shares of common stock to cover tax obligations upon the settlement of a Restricted Stock Unit award.